Trimodal Treatment Approaches for Inflammatory Breast Cancer - Takeaways - MDSpire

Trimodal Treatment Approaches for Inflammatory Breast Cancer

  • By

  • Audree B. Tadros

  • Risa Kiernan

  • April 9, 2026

  • 0 min

Share

  • 1

    Inflammatory breast cancer (IBC) has a 5-year survival rate of 55% to 70% without distant metastasis at presentation.

  • 2

    Trimodal therapy (TMT) improves survival outcomes for IBC patients but its use declined to less than 25% by 2020.

  • 3

    IBC patients exhibit worse survival rates compared to those with non-IBC locally advanced breast cancer.

  • 4

    Only 25.1% of IBC patients received guideline-concordant care, with many not undergoing appropriate surgical management.

  • 5

    Adherence to guideline-concordant care and exploring innovative treatments like neoadjuvant radiotherapy are crucial for improving IBC outcomes.

Original Source(s)

Trimodal Treatment Approaches for Inflammatory Breast Cancer

  • by Audree B. Tadros, Risa Kiernan

  • April 9, 2026

Related Content

Efficacy and safety of hypofractionated versus conventional radiotherapy in breast cancer: a systematic review and meta-analysis

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention